Eur Radiol:3D ABUS与HHUS在乳腺癌病变和BI-RADS特征显示的价值

2017-08-26 shaosai MedSci原创

现在,很多医院的乳腺钼靶片、B超检查和磁共振检查报告诊断为乳腺改变BI-RADS多少级,引起一些女性的无谓紧张,认为2级、3级就是癌症可能的2期、3期。其实,BI-RADS(Breast imaging reporting and data system)即美国放射学会推荐的"乳腺影像报告和数据系统"。本研究旨在评价自动乳腺超声(ABUS)与手持传统超声(HHUS)在显示乳腺病变和BI-RADS特

现在,很多医院的乳腺钼靶片、B超检查和磁共振检查报告诊断为乳腺改变BI-RADS多少级,引起一些女性的无谓紧张,认为2级、3级就是癌症可能的2期、3期。其实,BI-RADS(Breast imaging reporting and data system)即美国放射学会推荐的"乳腺影像报告和数据系统"。本研究旨在评价自动乳腺超声(ABUS)与手持传统超声(HHUS)在显示乳腺病变和BI-RADS特点的价值,并将结果发表在Eur Radiol上。

本研究自2016年1月-2017年1月共纳入了1886例乳腺密度分级为C或D的患者(年龄48.6±10.8岁),并行ABUS和HHUS检查;有1665例患者的亚组并行乳腺钼靶检查。

HHUS和ABUS的总体一致性为99.8%;kappa=0.994, p<0.0001。在HHUS中两例分级为BI-RADS 1,而在ABUS中分级为BI-RADS 4;病理结果为放射状瘢痕。3例乳腺癌在钼靶摄影分级为BI-RADS 2而在ABUS中分级为BI-RADS 4。另外2例在钼靶摄影中分级为BI-RADS 2 而在ABUS中分级为BI-RADS 5。2例乳腺癌在钼靶摄影中表现为边界清的肿块或形态欠规则,分级为BI-RADS 4,而在ABUS中分级为BI-RADS 5。

本研究表明,ABUS能够很好地显示乳腺病变及其BI-RADS特征。ABUS可能在冠状位显示形变要优于HHUS,能够对非钙化乳腺癌的检查中作为钼靶摄影的补充手段。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2029501, encodeId=da4d2029501c8, content=<a href='/topic/show?id=c4222014ff' target=_blank style='color:#2F92EE;'>#ADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2014, encryptionId=c4222014ff, topicName=ADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38232500109, createdName=1249898am15暂无昵称, createdTime=Mon Apr 30 22:14:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335989, encodeId=a70113359898c, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Mon Aug 28 01:14:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479625, encodeId=843914e962585, content=<a href='/topic/show?id=9754338920' target=_blank style='color:#2F92EE;'>#BI-RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3389, encryptionId=9754338920, topicName=BI-RADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e167558155, createdName=108807375_62823129, createdTime=Mon Aug 28 01:14:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792977, encodeId=961a1e92977b9, content=<a href='/topic/show?id=6d7e150911e' target=_blank style='color:#2F92EE;'>#RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15091, encryptionId=6d7e150911e, topicName=RADS)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Fri Mar 16 07:14:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=237333, encodeId=c6da23e33395, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sat Aug 26 10:21:05 CST 2017, time=2017-08-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2029501, encodeId=da4d2029501c8, content=<a href='/topic/show?id=c4222014ff' target=_blank style='color:#2F92EE;'>#ADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2014, encryptionId=c4222014ff, topicName=ADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38232500109, createdName=1249898am15暂无昵称, createdTime=Mon Apr 30 22:14:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335989, encodeId=a70113359898c, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Mon Aug 28 01:14:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479625, encodeId=843914e962585, content=<a href='/topic/show?id=9754338920' target=_blank style='color:#2F92EE;'>#BI-RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3389, encryptionId=9754338920, topicName=BI-RADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e167558155, createdName=108807375_62823129, createdTime=Mon Aug 28 01:14:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792977, encodeId=961a1e92977b9, content=<a href='/topic/show?id=6d7e150911e' target=_blank style='color:#2F92EE;'>#RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15091, encryptionId=6d7e150911e, topicName=RADS)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Fri Mar 16 07:14:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=237333, encodeId=c6da23e33395, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sat Aug 26 10:21:05 CST 2017, time=2017-08-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2029501, encodeId=da4d2029501c8, content=<a href='/topic/show?id=c4222014ff' target=_blank style='color:#2F92EE;'>#ADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2014, encryptionId=c4222014ff, topicName=ADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38232500109, createdName=1249898am15暂无昵称, createdTime=Mon Apr 30 22:14:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335989, encodeId=a70113359898c, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Mon Aug 28 01:14:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479625, encodeId=843914e962585, content=<a href='/topic/show?id=9754338920' target=_blank style='color:#2F92EE;'>#BI-RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3389, encryptionId=9754338920, topicName=BI-RADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e167558155, createdName=108807375_62823129, createdTime=Mon Aug 28 01:14:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792977, encodeId=961a1e92977b9, content=<a href='/topic/show?id=6d7e150911e' target=_blank style='color:#2F92EE;'>#RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15091, encryptionId=6d7e150911e, topicName=RADS)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Fri Mar 16 07:14:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=237333, encodeId=c6da23e33395, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sat Aug 26 10:21:05 CST 2017, time=2017-08-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2029501, encodeId=da4d2029501c8, content=<a href='/topic/show?id=c4222014ff' target=_blank style='color:#2F92EE;'>#ADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2014, encryptionId=c4222014ff, topicName=ADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38232500109, createdName=1249898am15暂无昵称, createdTime=Mon Apr 30 22:14:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335989, encodeId=a70113359898c, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Mon Aug 28 01:14:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479625, encodeId=843914e962585, content=<a href='/topic/show?id=9754338920' target=_blank style='color:#2F92EE;'>#BI-RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3389, encryptionId=9754338920, topicName=BI-RADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e167558155, createdName=108807375_62823129, createdTime=Mon Aug 28 01:14:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792977, encodeId=961a1e92977b9, content=<a href='/topic/show?id=6d7e150911e' target=_blank style='color:#2F92EE;'>#RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15091, encryptionId=6d7e150911e, topicName=RADS)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Fri Mar 16 07:14:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=237333, encodeId=c6da23e33395, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sat Aug 26 10:21:05 CST 2017, time=2017-08-26, status=1, ipAttribution=)]
    2018-03-16 江川靖瑶
  5. [GetPortalCommentsPageByObjectIdResponse(id=2029501, encodeId=da4d2029501c8, content=<a href='/topic/show?id=c4222014ff' target=_blank style='color:#2F92EE;'>#ADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2014, encryptionId=c4222014ff, topicName=ADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38232500109, createdName=1249898am15暂无昵称, createdTime=Mon Apr 30 22:14:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335989, encodeId=a70113359898c, content=<a href='/topic/show?id=792612047e' target=_blank style='color:#2F92EE;'>#3D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1204, encryptionId=792612047e, topicName=3D)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/pSGl6CJeZ2PzWxdhCtrvv4U9Q281RV8e0AKmlB5ib93DibbiaRyOzmkCdz5F04cbfX5RGOpG4dOXvuQW1fumibVeBg/132, createdBy=fc342500110, createdName=ms9833124466084992, createdTime=Mon Aug 28 01:14:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1479625, encodeId=843914e962585, content=<a href='/topic/show?id=9754338920' target=_blank style='color:#2F92EE;'>#BI-RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3389, encryptionId=9754338920, topicName=BI-RADS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e167558155, createdName=108807375_62823129, createdTime=Mon Aug 28 01:14:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792977, encodeId=961a1e92977b9, content=<a href='/topic/show?id=6d7e150911e' target=_blank style='color:#2F92EE;'>#RADS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15091, encryptionId=6d7e150911e, topicName=RADS)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK17mLkWpia3T92NlEWTkEhrhZa7XPNic2JqQumEicZXGYFG6Ww5SCIl0Uq62bhhPnibAqIZDHtRva92A/132, createdBy=e0752500025, createdName=江川靖瑶, createdTime=Fri Mar 16 07:14:00 CST 2018, time=2018-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=237333, encodeId=c6da23e33395, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Sat Aug 26 10:21:05 CST 2017, time=2017-08-26, status=1, ipAttribution=)]

相关资讯

Am J Clin Nutr:饮食代谢产物影响乳腺癌风险?

乳腺癌的发病涉及多种因素,饮食因素可能是其中一个重要影响因素。2017年8月,发表在《Am J Clin Nutr》的一项由美国科学家进行的前瞻性研究,考察了营养代谢产物与乳腺癌风险之间的相关性。

Ann Oncol:基线BMI和体重变化影响乳腺癌辅助化疗结局?

2017年,发表在《Ann Oncol》的一项由加拿大和美国科学家进行的研究,考察了CCTG辅助乳腺癌试验中,基线BMI和体重变化的影响。

Environmental Health Perspectives:光明下的肿瘤帮凶:夜间光照暴露增加患乳腺癌风险?

随着科技和生活的进步,越来越多的人生活在霓虹灯下的“不夜城”。可你是否会想到光照竟是恶性肿瘤的无形帮凶?可见光,顾名思义,是电磁波谱中人眼可以感知的部分,故而并不包括X光或其他损伤皮肤的紫外线。传统意义上,有害物质是剂量相关的:少而致伤,多可致毒。而可见光暴露的毒性无疑挑战着我们对于有毒物质的传统定义。可见光对人体健康的损害极其依赖于暴露的发生时间、而非所有的累积时间长度。百万年来,人类已经进化形

J Clin Invest:研究发现帮助对抗侵袭性乳腺癌的免疫细胞!

乳腺癌仍然是美国妇女与癌症相关死亡的主要原因。早期检测和靶向治疗改善了整体患者的疗效,但这些因素也深刻影响了预后。缺乏雌激素,孕激素和人类表皮生长因子2(HER2)激素受体表达的所谓“三阴”乳腺癌不能被现有的激素治疗所靶向,患者生存率差。三阴性乳腺癌的claudin-low亚型的特征在于其特异性较差的预后,以及肿瘤微环境中免疫细胞浸润的显著更高的速率。虽然观察结果表明,乳腺癌亚型中免疫浸润与患者预

JNCI:早期乳腺癌延长AI辅助治疗与哪些副反应呈正相关?

目前,已经有多个随机对照临床研究报道,在辅助5年内分泌治疗的基础上,进一步延长内分泌治疗的时长,可以改善患者的预后。但延长的AI辅助治疗,会不会增加毒副作用,目前尚未明确。近期,《JNCI》杂志发表了最新荟萃分析,纳入7个随机临床研究16349例患者,评估延长AI辅助治疗对患者心血管不良事件、骨折风险、其他部位第二原发癌、因不良事件中止治疗和复发前死亡的影响。背景绝经后早期乳腺癌患者术后辅助芳

CLIN CANCER RES:乳腺癌新辅助化疗过程中的转录反应

化疗导致的基因表达改变是由于肿瘤细胞转录重编或对于治疗的亚克隆适应。CLIN CANCER RES近期发表了一篇文章,研究对全转录组mRNA表达的影响,评估新辅助化疗联合贝伐单抗的治疗效果。